TY  - RPRT
TI  - in silico Assessment of Antibody Drug Resistance to Bamlanivimab of SARS-CoV-2 Variant B.1.617
AU  - Zhang, L.
AU  - Huynh, T.
AU  - Luan, B.
PY  - 2021
DO  - 10.1101/2021.05.12.443826
UR  - https://www.biorxiv.org/content/10.1101/2021.05.12.443826v1
ID  - 10.1101/2021.05.12.443826
ER  -